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A B S T R A C TObjectives: It is standard practice for diagnostic tests to be
evaluated against gold standards in isolation. In routine clinical
practice, however, it is commonplace for multiple tests to be used
before making definitive diagnoses. This article describes a meta-
analytic modeling framework developed to estimate the accuracy of
the combination of two diagnostic tests, accounting for the likely
nonindependence of the tests. Methods: A novel multicomponent
framework was developed to synthesize information available on
different parameters in the model. This allows data to be included
from studies evaluating single tests or both tests. Different like-
lihoods were specified for the different sources of data and linked by
means of common parameters. The framework was applied to
evaluate the diagnostic accuracy of the Ddimer test and the Wells
score for deep vein thrombosis, and the results were compared with
those of a model in which independence of tests was assumed. Allsee front matter Copyright & 2013, International
r Inc.
.1016/j.jval.2013.02.007
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ndence to: Alexander J. Sutton, Department of Healmodels were evaluated by using Bayesian Markov chain Monte Carlo
simulation methods. Results: The results showed the importance
of allowing for the (likely) nonindependence of tests in the meta-
analysis model when evaluating a combination of diagnostic tests.
The analysis also highlighted the relatively limited impact of those
studies that evaluated only one of the two tests of interest.
Conclusions: The models developed allowed the assumption
of independence between diagnostic tests to be relaxed while
combining a broad array of relevant information from disparate
studies. The framework also raises questions regarding the utility of
studies limited to the evaluation of single diagnostic tests.
Keywords: Bayesian methods, diagnostic accuracy, evidence synthesis.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Accurate diagnosis is a prerequisite for the efficient allocation of
treatments. Diagnostic tests with perfect or very high accuracy
(reference tests) are often expensive and/or invasive; therefore,
index tests, which are usually cheaper and less invasive but also
less accurate, often play an important role in medical diagnosis.
Rarely is the application of one index test sufficient to diagnose a
particular condition, and diagnostic strategies involving multiple
tests are often used in routine clinical practice. Where multiple
tests are used for diagnosis, however, it is important to acknowl-
edge that the diagnostic results from the different tests may not
be independent of one another, and therefore, when synthesizing
evidence to evaluate the accuracy of the combination of tests,
this interdependence needs to be taken into account, which is
seldom done in practice.
Systematic reviews and, consequently, meta-analyses are
routinely used to identify the evidence for medical decision
making [1] and, more specifically, for clinical/economic deci-
sion analytic modeling [2] because optimal decisions shouldnot be based solely on single study results when multiple
studies with relevant data exist [3,4]. Systematic reviews and
meta-analyses of diagnostic test accuracy studies have
focused on the performance of individual tests, which, at least
in part, is due to a large proportion of primary studies focusing
on the evaluation of single tests. A recent systematic review of
health technology assessment reports [5] found that where
economic decision models had been used to evaluate different
combinations of tests, the accuracy of each combination was
calculated on the basis of the assumption of either 1) condi-
tional independence between tests or 2) the accuracy of the
second test to be perfect. There is evidence that when the
assumption of dependence between tests is not met, both the
meta-analysis (for the estimates of the accuracy rates) and the
economic evaluation (informed by the meta-analysis results)
have the potential to give misleading conclusions [6]. In this
article, we focus solely on clinical effectiveness, with an
associated article [7] focusing on cost-effectiveness
implications.Society for Pharmacoeconomics and Outcomes Research (ISPOR).
on Methods for Evaluating Medical Tests and Biomarkers in
in Madrid, Spain, October 19-22, 2011.
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Table 1 – Data extracted by the systematic review of studies reporting both the Wells score and the
Ddimer test.
First author (year) Wells score accuracy data Ddimer test accuracy data
Stratum Diseased/total TP FP FN TN
Type A studies: Complete count data for the Ddimer test and the Wells score
T1. Shields (2002) Low 1/41 1 8 0 32
Moderate 6/44 6 18 0 20
High 10/17 8 2 2 5
T2. Lennox (1999) Low 4/88 3 8 1 76
Moderate 12/67 9 12 3 43
High 30/45 30 8 0 7
T3. Kearon (2001) Low 5/206 4 25 1 176
Moderate 24/188 17 51 7 113
High 35/49 33 8 2 6
T4. Ruiz-Gimenez (2004) Low 16/135 15 49 1 70
Moderate 31/136 31 51 0 54
High 55/112 54 36 1 21
T5. Yamaki (2005) Low 1/38 1 20 0 17
Moderate 22/64 22 23 0 19
High 35/56 35 9 0 12
T6. Anderson (2000) Low 4/118 4 17 0 97
Moderate 9/66 6 9 3 48
High 15/30 13 2 2 13
T7. Anderson (2002) Low 20/446 17 113 3 313
Moderate 76/192 61 93 15 23
High 94/199 79 55 15 50
T8. Bates (2003) Low 18/296 18 85 0 193
Moderate 17/189 16 83 1 89
High 21/71 21 30 0 20
T9. Rio Sola (1999) Low 28/32 23 1 5 3
Moderate 44/55 37 6 7 5
High 9/14 9 3 0 2
T10. Williams (2005) Low 6/89 6 42 0 41
Moderate 18/123 15 59 3 46
High 11/31 10 16 1 4
T11. Yamaki (2009) Low 29/505 28 233 1 243
Moderate 117/237 117 104 0 16
High 109/141 109 29 0 3
Type B studies: Complete count data for the Wells score and partial count data for the Ddimer test
T12. Borg (1997) Low 2/32 NA NA NA NA
Moderate 4/15 NA NA NA NA
High 26/29 25 2 1 1
T13. Dewar (2008) Low 9/166 9 70 0 87
Moderate 17/166 NA NA NA NA
High 30/108 NA NA NA NA
T14. Elf (2008) Low 13/159 12 37 1 109
Moderate 37/141 NA NA NA NA
High 33/57 NA NA NA NA
Type C studies: Partial count data for both the Wells score and the Ddimer test
T15. Aguilar-Franco (2002a) Low 2/149 2 76 0 71
Moderate NA/NA NA NA NA NA
High NA/NA NA NA NA NA
T16. Walsh (2009) Low 4/49 4 23 0 22
Moderate NA/NA NA NA NA NA
High NA/NA NA NA NA NA
T17. Aguilar-Franco (2002b) Low NA/NA NA NA NA NA
Moderate 26/134 26 73 0 35
High NA/NA NA NA NA NA
T18. Bucek (2002) Low 2/93 2 43 0 48
Moderate NA/NA NA NA NA NA
High NA/NA NA NA NA NA
FN, false negative; FP, false positive; NA, not available/reported; TN, true negative; TP, true positive.
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data, allowing for conditional dependence between tests; how-
ever, these consider data only from a single study. These include
1) the estimation of the covariance between test results condi-
tional on disease status [8–12], 2) use of latent variable models
[13–15], 3) use of linear discriminant procedures to select the best
combination of tests according to some maximizing functions
[16–22], and 4) use of approaches based on distribution-free
statistics [22–24]. Although the vast majority of the meta-
analytic methodological literature focuses on estimating the
performance of individual tests, Siadaty et al. [25] do consider
the simultaneous estimation of multiple tests, allowing for
dependency between patients for which multiple tests are avail-
able (i.e., where individual studies considered multiple tests). This
approach, however, did not consider the estimation of the accu-
racy of combinations of the tests considered in their framework.
Furthermore, there is a growing methodological literature [26] on
the estimation of multiple test performance in the absence of a
gold reference standard that has some commonalties with the
analyses presented here (though all studies included in our
syntheses are assumed to have a gold standard reference test).
In this article we propose—what we believe to be—the first
modeling framework developed to estimate meta-analytically the
accuracy of combinations of diagnostic tests, acknowledging the
likely nonindependence of the tests. The next section describes the
motivating example of the Ddimer test and the Wells score for the
diagnosis of deep vein thrombosis (DVT). The section on ‘‘Analysis
Framework’’ describes the meta-analytical modeling framework
developed to estimate the accuracy of combinations of diagnostic
tests. The results obtained by applying the framework developed
for the motivating example are presented in the ‘‘Results of the
Data Analysis’’ section, and the last section concludes the article.Motivating Example: The Ddimer Test and the Wells
Score for the Diagnosis of DVT
Background
DVT is a blood clot in a deep vein (lower limb) that is usually
treated with anticoagulants. Prompt treatment is essential to
lower the risk of mortality because of venous thrombo-
embolism–related potential adverse events. Also, because of the
potentially life-threatening side effects from anticoagulant treat-
ment, the number of patients wrongly diagnosed as having DVT
when they do not have the condition (i.e., false positives) needs
to be kept to a minimum. Therefore, it is important that an
accurate diagnosis of DVT is obtained quickly.
Reference tests with high diagnostic accuracy exist for DVT, such
as ultrasound or venography; however, several other index tests
exist that are less accurate but cheaper, quicker, and less invasive,
such as the Ddimer test and theWells score [27,28]. The Ddimer test
measures the concentration of an enzyme in the blood (i.e., the
higher the measurement, the more likely is the patient to have
DVT), and the Wells score is devised from an assessment of the
clinical features of DVT (i.e., clinical history, symptoms, and signs)
[28,29]. A simplified and widely used version of the Wells score (as
used in this article) categorizes patients into low (scoreo1), mod-
erate (score 1 or 2), and high (score42) risk of having DVT.
In a previous evaluation of the effectiveness and cost-
effectiveness of different tests for DVT, Goodacre et al. [27] found
that the Ddimer test and the Wells score were not accurate
enough as stand-alone diagnostic tools but that there was
evidence that test sequences containing both the Wells score
and the Ddimer test were potentially valuable; however, because
of the limited methodology available at the time, the approach
taken to account for test dependency was limited.The Data
We carried out an initial systematic review (details available on
request from the corresponding author) to identify publications
reporting accuracy data of the Ddimer test stratified by the Wells
score (for the common threefold categorization) either for all
Wells strata or for only specific stratum. The data identified
from this systematic review are presented in Table 1. Eleven
studies were identified that reported the diagnostic performance
of the Ddimer test for each of the three Wells score strata; these
data are subsequently referred to as type A. A further three
studies reported on each of the three Wells strata but had
Ddimer test results for only one of the three strata; these data
are subsequently referred to as type B. Next, for four further
studies, Wells performance data were available only from a single
stratum but for each of these reported strata, Ddimer test data
were also available; these data are subsequently referred to as
type C data.
In addition to these data, we include in our modeling frame-
work the considerable body of evidence on the diagnostic
accuracy of the Wells score alone and the Ddimer test alone.
We identify this literature through published systematic reviews
on the accuracy of the Wells score [30] (updated with study T33 in
Appendix A found at http://dx.doi.org/10.1016/j.jval.2013.02.007)
and the Ddimer test alone [31]), which are subsequently referred
to as type D data (n ¼ 18 studies) and type E data (n ¼ 97 studies),
respectively. (See Appendix A found at http://dx.doi.org/10.1016/
j.jval.2013.02.007 for inclusion criteria and references for all
included and excluded studies. Note that some studies of types
D and E reported multiple different tests/patient groups for which
data were analyzed as separate observations. We subsequently
refer to each set of observations from each study as an individual
assay.)The Diagnostic Strategies of the Wells Score and the Ddimer
Test
In the framework developed, we follow the two possible schemes
for combining two diagnostic tests outlined by Thompson [32]: 1)
believe the negative result (i.e., only patients diagnosed as
positive by the first test will be further tested) and 2) believe
the positive result (i.e., only patients diagnosed as negative by the
first test will be further tested). In this article we will limit
ourselves to evaluating the diagnostic accuracy of the two tests
alone and two strategies evaluating the use of the two tests in
combination as described below. Note that, for simplicity, we
have dichotomized the Wells score into low versus moderate and
high (though the approach would generalize to multiple catego-
ries and further categories are considered in the associated
economic evaluation article [7]).1. The Wells score dichotomized only as low versus moderate
and high2. The Ddimer test only at operative threshold as reported by the
manufacturer3. The Wells score followed by the Ddimer test using the believe
the negatives criterion4. The Wells score followed by the Ddimer test using the believe
the positives criterion
In strategies 3 and 4, we have chosen to evaluate strategies
in which the Wells score is used as the first diagnostic test
(because it is the quickest and least invasive, although order
does not affect overall test performance) followed by the
Ddimer test.
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Overview of Analysis Framework
Our overarching approach to analysis, which incorporates shared
parameter modeling [2], is as follows:1.T
T
T
T
T
T
T
T
Ndefine the basic intermediate parameters (i.e., the probability
of being diseased/healthy for each Wells stratum, and the
sensitivity and specificity of the Ddimer test stratified by Wells
strata) that can be estimated by using the data available;2. specify (different) likelihoods for each of the data types (A–E)
in terms of these basic intermediate parameters; and finally3. estimate the quantities of interest (i.e., the estimates of test
accuracy for combinations of tests) from the basic intermedi-
ate parameters through functional transformations.
A full description of the analysis framework is given below
(see sections ‘‘Defining and Estimating the Basic Intermediate
Parameters’’ and ‘‘Analysis Plan and Approach to Model Fitting’’).
Algebraic Notation of Data
Table 2 defines the algebraic notation used to describe the study
data and presents this below the reproduced data for types A, D,
and E. Type B and C data conform to the notation of type A but
with missing Ddimer test values for some of the Wells score
strata. For type E studies (Ddimer test data only), test accuracy
data are available for all patients and hence is notated as
aggregated across Wells score strata.
In Table 2, dki and hki define the number of diseased and
healthy individuals in the kth Wells stratum (i.e., 1 ¼ low; 2 ¼
moderate; 3 ¼ high) of the ith study. The total number of diseased
individuals and the total number of healthy individuals in the ith
study are defined as NDi and NHi, respectively.
For the accuracy of the Ddimer test, tpki is the number of
diseased patients who are correctly classified as positive by theable 2 – Algebraic notation.
ype of data Wells score accuracy
Stratum Diseas
ype A studies: Complete count data for the Ddimer test and the Wells
Low
Moderate
High
ype A (B and C incomplete versions of this) Low d1i/(
Moderate d2 /(
High d3 /(
ype D studies: Wells score data only
Low 7
Moderate 1
High 2
ype D Low d1 /(
Moderate d2 /(
High d3i/(
ype E studies: Ddimer test data only aggregated across Wells score stra
Low
Moderate
High
ype E Low
Moderate
High
A, not available/reported.Ddimer test (true positive) and tnki is the number of healthy
patients who are correctly classified as negative by the Ddimer
test (true negative) for the kthWells score stratum for the ith study.
Similarly, the number of healthy patients diagnosed as diseased
(false positives) and the number of diseased patients diagnosed as
healthy (false negatives) can be defined as stated in Table 2.
Sensitivity (i.e., the proportion of diseased patients who are
correctly identified by the test) and specificity (i.e., the proportion
of healthy patients who are correctly identified by the test) of the
Ddimer test for the kth Wells score stratum for the ith study can
be derived from the above quantities as follows:
senski¼
tpki
dki
specki¼
tnki
hki
The synthesis model used to combine the data available from
each study is described in the next section.
Defining and Estimating the Basic Intermediate Parameters
As described in the previous section, the relation between the
data and the intermediate parameters is presented via the
description of the likelihoods and using a multicomponent model
with shared parameters. In the account that follows, the number
of studies of types A, B, C, D, and E are denoted as nA, nB, nC, nD,
and nE, respectively.
Wells score strata data (types A, B, C, and D): Multinomial
random effects logistic meta-analysis model
Complete Wells score strata data (types A, B, and D) are modeled
by using a multinomial logistic regression model in the form
presented by Ntzoufras [33] adapted to fit between-study random
effects to account for heterogeneity. The likelihood for these data
is specified via multinomial distributions (see Equation 1), with
parameters pDki indicating the probability of being in the kth
(¼1–3) Wells stratum for a diseased patient in the ith study anddata Ddimer test accuracy data
ed/total TP FP FN TN
score
1/41 1 8 0 32
6/44 6 18 0 20
10/17 8 2 2 5
d1i þ h1i) tp1i h1i  tn1i d1i  tp1i tn1i
d2i þ h2i) tp2i h2i  tn2i d2i  tp2i tn2i
d3i þ h3i) tp3i h3i  tn3i d3i  tp3i tn3i
0/880 NA NA NA NA
35/501 NA NA NA NA
28/345 NA NA NA NA
d1i þ h1i) NA NA NA NA
d2i þ h2i) NA NA NA NA
d3i þ h3i) NA NA NA NA
ta
NA 17 46 1 24
NA
NA
NA P3
k¼1
tpki
P3
k¼1
hkitnki
P3
k¼1
dkitpki
P3
k¼1
tnkiNA
NA
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stratum for a healthy patient.
ðd1i, d2i, d3iÞ multinomððpD1i, pD2i, pD3iÞ; NDiÞ
ðh1i, h2i, h3iÞ multinomððpH1i, pH2i, pH3iÞ; NHiÞ
for i from 1 to nAþnB ðtype A,BÞ and
for i from nAþnBþnCþ1 to nAþnBþnCþnD ðtype DÞ ð1Þ
where all other notations are as defined in the previous section.
For incomplete Wells score strata data (type C), the multi-
nomial likelihoods cannot be used because of the missing data.
Note that type C data will influence neither the estimate of the
intermediate parameters nor the estimate of the final parameters
for the Wells score but will contribute to the estimation of the
conditional accuracy of the Ddimer test. A combination of
binomial likelihoods is used instead of the multinomial like-
lihood. The assumption of exchangeability between studies [34]
allows for the estimation of the missing strata data and the pDki’s
and pHki’s when summed over k are constrained to 1. Further-
more, to allow the estimation of the missing denominator data
(as denoted by N^Di and N^Hi), exchangeability between studies is
assumed via the indirect estimation of the parameter for which
there is no information (see below).
dki binomialðpDki; N^DiÞ
hki binomialðpHki, N^HiÞ
for i from nAþnBþ1 to nAþnBþnC ðtype CÞ
for k¼1, 2 and 3 ð2Þ
Type A, B, C, and D data are then synthesized by using a
random effects structure with common between-study variability
(on a logit scale). The transformed parameters xDki and xHki are
assumed to be exchangeable from distributions with mean
parameters xDk and xHk for Wells score level (k) 1 ¼ low, 2 ¼
moderate, and 3 ¼ high. The degree of heterogeneity is assumed
to be the same across the three diseased and healthy Wells score
strata, and the between-study variance is represented by s2D
and s2H, respectively. Note how the likelihoods in both Equations
1 and 2 are linked by means of the parameters ZDk and ZHk in
Equation 3.
pDki¼
ZDkiP2
k¼1 ZDki
, xDki¼ lnðZDkiÞ
pHki¼
ZHkiP2
k¼1 ZHki
, xHki¼ lnðZHkiÞ ð3Þ
xDki NormalðxDk, s2DÞ; xHki NormalðxHk, s2HÞ
for i from 1 to nAþnBþnCþnD ðtypes A, B, C, and DÞ
for WS levelðkÞ 1¼ low, 2¼moderate and 3¼high
The overall meta-analyzed proportions of diseased and healthy
patients in each of the k Wells score strata (ppooledDk and p
pooled
Hk ,
respectively) are the basic intermediate parameters of interest.
These are obtained by the following back-transformations:
ppooledDk ¼
expðxDkÞP3
k¼1 expðxDkÞ
ppooledHk ¼
expðxHkÞP3
k¼1 expðxHkÞ
ð4Þ
for k ¼ 1 to 3 strata.Ddimer test data stratified by the Wells score (type A, B, and C
data): Bivariate random effects logistic meta-analysis model
Type A, B, and C data that provide Wells score stratum-specific
Ddimer test accuracy data are modeled as three separate bivari-
ate random effects models [35]—one for each stratum. Theformulation of the model allows for missing strata data, which
exists for both type B and type C studies. In addition, for type C
data, the total number of diseased patients (dki) and the total
number of healthy patients (hki) are missing; however, these are
estimated by the model for the meta-analysis of the Wells score
data as specified in section ‘‘Analysis Framework’’. Algebraically,
tpki binomialðsenski,dkiÞ tnki binomialðspecki, hkiÞ
logitðsenskiÞ¼mDki logitðspeckiÞ¼mHki
mDki
mHki
 !
MultivariateNormal M¼
mDk
mHk
 !
,
X
¼
s2Dk sDHk
sHDk s2Hk
 !" #
for i in 1 to nAþnBþnC ðtypes A,B, and CÞ and
for WS levelðkÞ 1¼ low, 2¼moderate and 3¼high ð5Þ
where mDki and mHki are the logit sensitivity and specificity,
respectively, in the kth Wells score stratum of the ith study, M
is the vector of mean logit responses containing mDk and mHk (i.e.,
the mean logit sensitivity and specificity in the kth Wells score
stratum, respectively), and
P
is the between-study covariance
matrix containing the between-study variances ðs2Dk, s2HkÞ for logit
sensitivity and specificity, respectively, and the covariance ðs2DHkÞ
in the kth Wells score stratum.
A back-transformation is required to estimate the sensitivity
and specificity of the Ddimer test for each of the k (¼1–3) Wells
score strata as presented below:
specpooledk ¼
expðmDkÞ
1þexpðmDkÞ
specpooledk ¼
expðmHkÞ
1þexpðmHkÞ
ð6Þ
Ddimer test data alone (type E data) aggregated across Wells
strata: Bivariate random effects logistic meta-analysis model
To include type E data, which provides information on the
accuracy of the Ddimer test aggregated across Wells strata, it is
assumed that the overall accuracy of the Ddimer test is a
function of the proportion of diseased and healthy patients in
each Wells score stratum and the Wells score stratum-specific
accuracy performance parameters of the Ddimer test. The model
is fitted as follows: A bivariate logit model of the form outlined in
Equation 5 is used to meta-analyze the overall accuracy of the
Ddimer test aggregated across Wells strata (i.e., stratum-specific
indexing dropped from the summary parameters).
TP:aggi binomialðsens:aggi,NDiÞ; TN:aggibinomialðspec:aggi,NHiÞ
logitðsens:aggiÞ¼m:aggDi; logitðspec:aggiÞ¼m:aggHi
m:aggDi
m:aggHi
 !
¼MVN M¼
m:aggD
m:aggH
 !
,
X
¼
s:agg2D s:aggDH
s:aggHD s:agg
2
H
 !" #
for i in nAþnBþnCþnDþ1 to nAþnBþnCþnDþnE ðtype EÞ ð7Þ
where parameters are of the form described in Equation 5, but
‘‘.agg’’ is added to parameters to indicate aggregation across Wells
strata.
The aggregate Ddimer test accuracy parameters, estimated in
Equation 7, are now expressed as functions of the parameters used
to define the stratum-specific accuracy model. Explicitly, because
we do not know the proportion of diseased and healthy patients in
each Wells score stratum for these studies, we predict these
proportions stochastically assuming them to be exchangeable with
the studies for which we do know the proportions (i.e., data types A,
B, C, and D). We then express the aggregate Ddimer test accuracies
as ‘‘weighted’’ averages of the Wells score strata (i.e., weighted by
the predicted proportions in each Wells stratum described above).
Algebraically, the (logit) predicted proportions of patients in
each Wells score stratum for diseased and healthy are defined as
xnewDki and x
new
Hki , respectively, where each is assumed to be exchange-
able with the logit proportions estimated from the previous
Table 3 – Estimates (with their 95% credible intervals in parentheses) of the proportions of diseased and
healthy patients and the performance accuracy of the Ddimer test in the kth Wells score stratum for the
models assuming independence and dependence between tests.
Model Description Parameter Wells score
Low (k ¼ 1) Moderate (k ¼ 2) High (k ¼ 3)
Independence
between tests
Overall proportion of
diseased patients in the
kth Wells score stratum
ppooledDk
0.121 (0.096– 0.148) 0.345 (0.295– 0.398) 0.534 (0.479–0.591)
Overall proportion of healthy
patients in the kth Wells
score stratum
ppooledHk
0.497 (0.416– 0.576) 0.385 (0.312– 0.462) 0.118 (0.087–0.153)
Between-study heterogeneity
for diseased patients
sD 0.223 (0.124–0.368)
Between-study heterogeneity
for healthy patients
sH 0.665 (0.263–5.710)
Sensitivity of the Ddimer test
aggregated across Wells
score strata
senspooled 0.930 (0.919–0.941)
Specificity of the Ddimer test
aggregated across Wells
score strata
specpooled 0.552 (0.522–0.583)
Between-study heterogeneity
standard deviation for
logit(sensitivity)
sD 0.223 (0.124–0.368)
Between-study heterogeneity
standard deviation for
logit(specificity)
sH 0.665 (0.263–5.710)
Covariance heterogeneity
parameter
sDH 0.544 (0.731 to 0.382)
Correlation logit(sensitivity)
and logit(specificity)
p 0.586 (0.697 to 0.459)
Allowing for
dependency
between tests
Overall proportion of
diseased patients in the
kth Wells score stratum
ppooledDk
0.127 (0.105–0.152) 0.347 (0.301– 0.394) 0.526 (0.476– 0.577)
Overall proportion of healthy
patients in the kth Wells
score stratum
ppooledHk
0.482 (0.422–0.540) 0.406 (0.351– 0.464) 0.112 (0.089– 0.138)
Between-study heterogeneity
for diseased patients
sD 0.170 (0.094–0.282)
Between-study heterogeneity
for healthy patients
sH 0.298 (0.199–0.437)
Sensitivity of the Ddimer test
for the kth Wells score
stratum
senspooledk
0.930 (0.863–0.981) 0.957 (0.893– 0.995) 0. 960 (0.933– 0.982)
Specificity of the Ddimer test
for the kth Wells score
stratum
specpooledk
0.699 (0.598–0.797) 0.390 (0.212– 0.561) 0.433 (0.300– 0.566)
Between-study heterogeneity
standard deviation for
logit(sensitivity)
sDk 1.979 (0.277–6.768) 7.957 (2.813– 19.960) 1.093 (0.426– 2.296)
Between-study heterogeneity
standard deviation for
logit(specificity)
sHk 1.597 (0.664–3.082) 3.934 (1.393– 8.029) 0.905 (0.213– 2.538)
Covariance heterogeneity
parameter
sDHk 1.358 (3.633 to 0.103) 4.633 (9.844 to 1.711) 0.623 (1.673 to 0.016)
Correlation logit(sensitivity)
and logit(specificity)
pk 0.747 (0.977 to 0.007) 0.845 (0.953 to 0.675) 0.632 (0.922 to 0.026)
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xnewDki  NormalðxDk,s2DÞ
xnewHki  NormalðxHk,s2HÞ ð8Þ
for i in nAþnBþnCþnDþ1 to nAþnBþnCþnDþnE (type E)
where all other parameters are as defined in Equation 3. Equa-
tion 9 below defines the proportion of individuals predicted to bediseased or healthy on the natural scale for each kth Wells
stratum (pnewDki and p
new
Hki , respectively).
pnewDki ¼
expðxnewDki ÞP3
k¼1 expðxnewDki Þ
pnewHki ¼
expðxnewHki ÞP3
k¼1 expðxnewHki Þ
ð9Þ
for i in nAþnBþnCþnDþ1 to nAþnBþnCþnDþnE (type E)
VA L U E I N H E A LT H 1 6 ( 2 0 1 3 ) 6 1 9 – 6 2 8 625Next, we express the overall sensitivity and specificity as the
‘‘weighted’’ average of the Wells stratum-specific values of interest.
sens:aggi¼
X3
k¼1
senski  pnewDki
spec:aggi¼
X3
k¼1
specki  pnewHki ð10Þ
for i in nAþnBþnCþnDþ1 to nAþnBþnCþnDþnE (type E)
By doing this, type E data will contribute information to the
Wells stratum-specific estimate of the Ddimer test performance.
Estimating the accuracy parameters of interest from the basic
intermediate parameters
The parameters of ultimate interest are the accuracies of the
different diagnostic strategies (sensitivities and specificities) as
outlined in section ‘‘Analysis Framework.’’ How these are esti-
mated from the intermediate parameters, as described in the
previous section, is presented below.
Strategy 1: Wells score dichotomized only as low versus
moderate and high. The parameters estimated in the previous
section can be used to estimate the accuracy of the
Wells score dichotomized as low versus moderate and high. That
is, the sensitivity (sensWS) is pD2þpD3 and specificity (specWS) is pH1.
Strategy 2: The Ddimer test only at the operative threshold as
reported by the manufacturer. The accuracy of the Ddimer test
on its own is not obtained from the multicomponent model
described previously because a standard synthesis model for a
single test is all that is required. Ddimer test data from type A
studies are aggregated over Wells score strata. This is combined
with type E data and then analyzed by using a bivariate random
effects logit model [36].
Strategy 3: The Wells score followed by the Ddimer test using
the believe the negatives criterion. The accuracy of the Wells
score dichotomized as low versus moderate and high using the
believe the negatives strategy (i.e., a patient is considered healthy
if either or both test results are negative) can be derived by using
the following formulas:
sensðWS and DDÞBN ¼sensWS  sensDD=WS¼2,3
where sensDD=WS¼2,3¼ðwD1  senspooled2 ÞþðwD2  senspooled3 Þ
andwD1¼
pD2
pD2þpD3
, wD2¼1wD1
specðWS and DDÞBP ¼1½ð1specWSÞ  ð1specDD=WS¼2,3Þ
where specDD=WS¼2,3¼ðwH1  specpooled2 ÞþðwH2  spec
pooled
3 Þ
andwH1¼
pH2
pH2þpH3
, wH2¼1wH1 ð11Þ
where sensDD/WS¼2,3 and specDD/WS¼2,3 are the sensitivity and
specificity of the Ddimer test for the combined Wells score
moderate (k ¼ 2) and high (k ¼ 3) strata.
Strategy 4: The Wells score followed by the Ddimer test using
the believe the positives criterion. The accuracy of the Wells
score dichotomized as low versus moderate and high using the
believe the positives ((WS and DD)BP) strategy can be derived by
using the following formulas:
sensðWS and DDÞBP ¼1½ð1sensWSÞ  ½ð1sens
pooled
1 Þ
specðWS and DDÞBP ¼specWS  spec
pooled
1 ð12ÞAnalysis Plan and Approach to Model Fitting
The modeling framework is implemented by using Markov chain
Monte Carlo (MCMC) simulation [37] in WinBUGS software [38] for
Bayesian modeling. Noninformative (vague) previous distributions
are used for all parameters. An initial run of 5,000 iterations of the
MCMC sampler were discarded as a ‘‘burn-in’’ [38], with inferences
based on a further 20,000 sample iterations. Convergence of the
MCMC chains was assessed, and sensitivity analyses showed no
influence of the initial values and previous distributions on the
posterior distributions obtained. The WinBUGS code (including the
specific previous distributions used) is provided in Appendix B found
at http://dx.doi.org/10.1016/j.jval.2013.02.007.
The model described above was fitted to all data types (A, B, C,
D, and E) and is compared to an analysis in which the perform-
ance of both tests is assumed independent of one another. In
addition, to assess the impact of the different data types on the
analysis, a further analysis was conducted in which each data
type was sequentially added (i.e., A, AB, ABC, ABCD, and ABCDE).Results of the Data Analysis
Estimates of Basic Intermediate Parameters
Table 3 presents and compares the estimates of the basic
intermediate parameters for the models assuming independence
and dependence between the Wells score and the Ddimer test.
From Table 3 it can be observed that the proportions of diseased
patients per Wells score stratum are similar regardless of the
dependency assumption. Reassuringly, in both cases, the propor-
tion of diseased individuals increases and the proportion of
healthy individuals decreases with each Wells score stratum. In
Table 3, the performance accuracy of the Ddimer test for each
Wells score stratum is reported. Although sensitivity does vary
across Wells score strata, it is specificity for which the biggest
differences are observed (even though with considerable uncer-
tainty). That is, for the model that assumes dependence between
tests, specificity for the low-risk Wells score stratum is estimated
to be 0.699 (0.598–0.797); for moderate, 0.390 (0.212–0.561); and for
high, 0.433 (0.300–0.566). In Table 3, all heterogeneity parameters
are nonnegligible, suggesting that variability between study
results is greater than would be expected by chance. Such
heterogeneity could be explored by adding covariates to the
models presented, although, to keep this article’s methodological
innovations focused, this is not investigated further here.
Figure 1 displays the 95% credible regions [39,40] for the
overall accuracy of the Ddimer test (across all Wells score strata)
compared with the Wells score stratum-specific accuracy esti-
mates. This plot highlights the potentially important differences
in the performance of the Ddimer test for different Wells score
strata. If the assumption of independence between the Wells
score and the Ddimer test was true, then we would expect the
four different credible regions displayed to be overlaid on top of
one another but considerable divergence is observed.
Estimates of Final Parameters
Table 4 presents the results of the four different strategies of the
Wells score and the Ddimer test described in section ‘‘Analysis
Framework’’ for the models assuming independence and depend-
ence between tests. When comparing these two modeling
approaches, it can be observed that the sensitivities of different
strategies are similar for both the independent and dependent
models but differences are observed for the specificities although
all the credible intervals overlap. The implications of the per-
formance of these different strategies are considered further in a
full economic analysis elsewhere [7].
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Fig. 1 – Ninety-five percent credible regions for the accuracy of the Ddimer test overall and the Ddimer test stratified by Wells
score stratum based on data types A, B, C, and E. Note: Each study may have evaluated a number of different assays (i.e.,
types of Ddimer tests) and therefore the number of assays is greater than the number of studies.
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sequentially adding the different data types (i.e., A, AB, ABC,
ABCD, and ABCDE). It can be observed that there is relatively
limited impact, in terms of both point estimate and uncertainty,
of adding data from the studies that evaluated only one of the
two tests of interest (i.e., types D and E), although there are
relatively higher numbers of these types of studies compared
with the other data types (types A, B, and C).Discussion
This article presents a meta-analytic framework that allows for
the fact that the performance of multiple diagnostic tests, when
used in combination, may not be independent of one another.
This is in contrast to current practice in health technology
assessment, where independence between tests is commonly
assumed [5] (which is potentially misleading and can lead to the
overestimation of the performance of combinations of tests). We
believe that this is the first published methodological research in
this aspect of evidence synthesis methodology.
Our overall approach, in which the relationship to disparate
data sources is expressed by using multiple likelihood functions
sharing common parameters, has much in common with other
recent developments in evidence synthesis methodology in other
contexts [36,41,42]. Such an approach allows the use of data fromTable 4 – Estimates of the accuracy (sensitivity and spec
and the Wells score.
Strategy Mod
Ddimer test only Indepen
Depend
Wells score only Indepen
Depend
Wells score and Ddimer test (believe the negatives) Indepen
Depend
Wells score and Ddimer test (believe the positives) Indepen
Dependstudies reporting on the accuracy of individual tests or multiple
tests given to the same patients (completely or incompletely
reported). In this way, the amount of data that can be incorporated
from the literature is maximized. The approach described could
be adapted to the case in which both tests are dichotomous, and
extensions to incorporate three or more tests or situations in
which the gold standard is imperfect could be developed. Fur-
thermore, we were interested in evaluating the overall perform-
ance of a sequence of tests; a similar approach may be used to
evaluate the performance of tests that compete for the same
location in a given diagnostic pathway.
We believe that this work has an important message for those
funding and conducting new studies estimating the diagnostic
accuracy of tests. In the DVTexample presented here, the majority
of research had been carried out in studies evaluating only a single
test (i.e., data types D and E). This, perhaps, is at discord with
clinical practice in which we believe that it is commonplace for
multiple tests to be used to diagnose patients. In the motivating
example, at least, the literature on the individual studies had
minimum impact on the estimation of the sequences of tests of
interest. Although this finding needs further investigation (includ-
ing application in other clinical contexts), the potential implication
is that studies of individual tests are highly inefficient if test
sequences are of ultimate interest and therefore our research
would suggest that studies evaluating multiple tests should
replace many of the studies of individual tests currently performedificity) for the final combinations of the Ddimer test
el Sensitivity Specificity
dent 0.930 (0.919–0.941) 0.552 (0.522–0.583)
ent 0.936 (0.871–0.977) 0.624 (0.502–0.733)
dent 0.879 (0.852–0.904) 0.497 (0.416–0.576)
ent 0.873 (0.848–0.895) 0.482 (0.422–0.540)
dent 0.818 (0.790–0.844) 0.775 (0.735–0.813)
ent 0.837 (0.709–0.863) 0.689 (0.608–0.761)
dent 0.992 (0.989–0.994) 0.275 (0.227–0.321)
ent 0.991 (0.983–0.998) 0.337 (0.280–0.397)
VA L U E I N H E A LT H 1 6 ( 2 0 1 3 ) 6 1 9 – 6 2 8 627carefully, ensuring appropriate clinical context. On completion of
our work, we were heartened to see a new prospective cohort
study evaluating the combined performance of theWells score and
the Ddimer test in a primary care setting [43]. Indeed, the findings
reported here lead us to the question, when carrying out such
syntheses, whether identification and synthesis of studies report-
ing individual tests is even justifiable—given the resource
implications—when evaluating test combinations.
As this was a methodological article, we relied on previous
meta-analyses of the performance of the Ddimer test and the
Wells score and we acknowledge that these have limitations thatTable 5 – Estimates of the accuracy (sensitivity and
specificity) and number of assays (n) for the final
combinations of the Ddimer test and the
Wells score.
Type of data Sensitivity Specificity N
Ddimer test alone
A 0.940
(0.889–0.974)
0.609
(0.516–0.699)
11
AB 0.942
(0.893–0.975)
0.603
(0.517–0.686)
14
ABC 0.948
(0.905–0.977)
0.593
(0.516–0.669)
18
ABCD 0.949
(0.910–0.977)
0.582
(0.505–0.657)
38
ABCDE 0.936
(0.871–0.977)
0.624
(0.502–0.733)
233
Wells score alone
A 0.864
(0.802–0.915)
0.522
(0.420–0.617)
11
AB 0.865
(0.812–0.908)
0.527
(0.444–0.605)
14
ABC 0.871
(0.821–0.914)
0.571
(0.472–0.665)
18
ABCD 0.876
(0.851–0.900)
0.511
(0.447–0.576)
38
ABCDE 0.873
(0.848–0.895)
0.482
(0.422–0.540)
233
Wells score and Ddimer test (believe the negatives)
A 0.815
(0.740–0.876)
0.754
(0.669–0.830)
11
AB 0.816
(0.750–0.871)
0.756
(0.678–0.827)
14
ABC 0.826
(0.764–0.879)
0.779
(0.705–0.845)
18
ABCD 0.833
(0.788–0.870)
0.749
(0.680–0.813)
38
ABCDE 0.837
(0.709–0.863)
0.689
(0.608–0.761)
233
Wells score and Ddimer test (believe the positives)
A 0.989
(0.976–0.997)
0.376
(0.282–0.469)
11
AB 0.990
(0.980–0.997)
0.374
(0.297–0.453)
14
ABC 0.992
(0.984–0.998)
0.384
(0.301–0.470)
18
ABCD 0.993
(0.985–0.998)
0.345
(0.280–0.411)
38
ABCDE 0.991
(0.983–0.998)
0.337
(0.280–0.397)
233include the following: 1) studies of different Ddimer test products
were combined together, 2) considerable heterogeneity in study
results was not explored by the incorporation of covariates
(although the framework presented would allow this extension),
and 3) issues of variable study quality are largely ignored.
We appreciate the interpretation of the findings of the type of
analyses presented here need careful consideration. For the moti-
vating example (Table 4), identifying an optimal strategy is not
straightforward because an explicit trade-off between sensitivity
and specificity is required for decision making. To do this, among
other things, the relative impact of a false-positive diagnosis
compared with a false-negative diagnosis will need consideration.
Furthermore, economic considerations are increasingly relevant
and thus the economic consequences of the alternative clinical
pathways will also be necessary, and we extend our research in a
further article to demonstrate how this can be achieved [7].
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